LLY · earnings call history
Eli Lilly Q1 FY26 — Strong Growth Driven by Incretins and Foundayo Launch
Read the briefEli Lilly Q4 FY25 — Robust Growth Driven by Key Products and Pipeline Expansion
Read the briefEli Lilly Q3 FY25 — Strong Growth Across Key Products and Raised Guidance
Read the briefBrowse all US companies on the earnings-call register.